SB-235699 T28684
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
SB-235699, a p38 MAPK inhibitor, is used potentially for the treatment of psoriasis.
CAS nr:
180869-32-3
Purity:
98%
Molecular Weight:
322,39
SMILES:
FC1=CC=C(C2=C(C3=CC=NC=C3)N(C4CCNCC4)C=N2)C=C1
Formula:
C19H19FN4
Pathway:
Target:
